Cite
A Potential Serum Biomarker, Albumin-to-Glutamyltransferase Ratio, Suggests the Severity of Liver Disease.
MLA
Pan, Nannan, et al. “A Potential Serum Biomarker, Albumin-to-Glutamyltransferase Ratio, Suggests the Severity of Liver Disease.” Clinical Laboratory, vol. 66, no. 5, May 2020. EBSCOhost, https://doi.org/10.7754/Clin.Lab.2019.190826.
APA
Pan, N., Liu, J., Deng, H., Zheng, W., Cui, S., Wei, W., Lan, X., Yu, H., Wang, J., & Xiao, L. (2020). A Potential Serum Biomarker, Albumin-to-Glutamyltransferase Ratio, Suggests the Severity of Liver Disease. Clinical Laboratory, 66(5). https://doi.org/10.7754/Clin.Lab.2019.190826
Chicago
Pan, Nannan, Jinlian Liu, Huimin Deng, Wenbin Zheng, Shengjin Cui, Wei Wei, Xi Lan, Huijun Yu, Jing Wang, and Lijia Xiao. 2020. “A Potential Serum Biomarker, Albumin-to-Glutamyltransferase Ratio, Suggests the Severity of Liver Disease.” Clinical Laboratory 66 (5). doi:10.7754/Clin.Lab.2019.190826.